Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked

In Central Eurasia, the availability of drugs that are inhibitors of the SARS-CoV-2 virus and have proven clinical efficacy is still limited. The aim of this study was to evaluate the activity of drugs that were available in Kazakhstan during the acute phase of the epidemic against SARS-CoV-2. Antiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhurinov, Murat Zh., Miftakhova, Alfira F., Keyer, Viktoriya, Shulgau, Zarina T., Solodova, Elena V., Kalykberdiyev, Maxat K., Abilmagzhanov, Arlan Z., Talgatov, Eldar T., Ait, Sauyk, Shustov, Alexandr V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458004/
https://www.ncbi.nlm.nih.gov/pubmed/37630394
http://dx.doi.org/10.3390/molecules28166142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458004/
https://www.ncbi.nlm.nih.gov/pubmed/37630394
http://dx.doi.org/10.3390/molecules28166142

Ejemplares similares